NCT00053989 2020-02-10NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersRoswell Park Cancer InstitutePhase 2 Completed41 enrolled 13 charts
NCT00281879 2017-09-27Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerOHSU Knight Cancer InstitutePhase 2 Terminated200 enrolled 11 charts
NCT00521430 2013-03-26Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseNational Cancer Institute (NCI)Phase NA Completed30 enrolled
NCT00005641 2012-12-11Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Terminated